Harmed By Avandia?

Oklahoma City Personal Injury Attorney

It is estimated that approximately 1 million patients in the United States are currently taking Avandia (generic name: rosiglitazone). This popular drug is intended to treat Type 2 diabetes by improving blood sugar control. Since its approval by the Food and Drug Administration (FDA) in 1999, Avandia has been linked to serious cardiovascular side effects.

Because a diabetic patient will already be at an increased risk of cardiac problems, taking Avandia may only increase that risk and may therefore have deadly results. These risks spurred the FDA to demand GlaxoSmithKline to include a black-box warning on Avandia.

In addition to cardiovascular events such as heart attack or stroke, Avandia may be linked to such side effects as liver toxicity, low blood pressure, edema, weight gain, elevated lipids and anemia. If you or a loved one was prescribed Avandia and has experienced any dangerous side effect as a result, it is important to consider your legal rights.

An Oklahoma City injury lawyer at the Law Offices of Stipe & Belote can meet with you to talk about what occurred and whether you have grounds for a lawsuit against the pharmaceutical company or perhaps your doctor for prescribing Avandia when this was a hazard to your health.

Avandia Injury Lawyer Serving You

Ensure the full protection of your legal rights and the proper presentation of your drug injury claim by involving an attorney who has the experience and resources to go to bat for you. We are not afraid to go up against pharmaceutical giants to protect our clients' rights and interests.

If Avandia or any type of dangerous prescription drug caused you injury or led to the loss of a loved one, we can help.

Free Case Evaluation

Fill out the contact form below to tell us about your case and find out how our team can help you.

    • Please enter your name.
    • This isn't a valid phone number.
      Please enter your phone number.
    • This isn't a valid email address.
      Please enter your email address.
    • Please make a selection.
    • Please enter a message.